Martinrea International (MRE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Q1 2026 sales were $1,125.4 million, down 3.7% year-over-year, with production sales declining 3.9% and tooling sales up 1.5%.
Adjusted operating income margin improved to 5.5%, up 20 basis points year-over-year and 90 basis points sequentially, with adjusted operating income at $61.6 million.
Adjusted net earnings per share rose to $0.45 from $0.41, driven by lower finance expense, FX loss, and tax rate.
Launched TruNorth Kaizen consultancy, winning contracts in aerospace and defense, and acquired Lyseon North America, contributing to new revenue streams.
2026 outlook reaffirmed, with strong quoting momentum and new business awards totaling $370 million over the last 12 months.
Financial highlights
Gross margin was $149.2 million (13.3% of sales), up 0.3 percentage points year-over-year.
Adjusted EBITDA was $137.7 million (12.2% margin), slightly down from $140.9 million a year ago.
Free cash flow was negative $35.2 million due to seasonal working capital, but full-year free cash flow guidance was reaffirmed.
Repurchased 1.1 million shares (~1.5% of shares) for $11 million in Q1; net debt to EBITDA at 1.6x.
Book value per share has more than tripled since 2014.
Outlook and guidance
2026 guidance reaffirmed: total sales of $4.5–$4.9 billion, adjusted operating income margin of 5.5–6%, and free cash flow of $125–$175 million.
Outlook assumes modest sales decline due to Ford Escape program end and lower tooling sales.
Margin expansion expected from operational improvements, automation, and commercial recoveries.
Management expects to maintain leverage within the 1.5x net debt to adjusted EBITDA target.
Capex planned at approximately $300 million, with lower restructuring costs than 2025.
Latest events from Martinrea International
- Strong growth, innovation, and sustainability drive industry-leading performance and EV readiness.MRE
Investor presentation30 Apr 2026 - Record Free Cash Flow and margin gains in 2025 set the stage for continued growth and expansion.MRE
Q4 202525 Apr 2026 - Record Q2 adjusted EBITDA, strong cash flow, and stable 2024 outlook despite industry headwinds.MRE
Q2 20242 Feb 2026 - Q3 saw lower sales and earnings but stronger margins, cash flow, and improved leverage.MRE
Q3 202414 Jan 2026 - Impairments and lower sales drove a net loss, but Free Cash Flow and margins remained resilient.MRE
Q4 20243 Dec 2025 - Sales and margins declined year-over-year, but new awards and cost focus support future outlook.MRE
Q1 202528 Nov 2025 - Margins and free cash flow improved in Q2 2025, with 2025 guidance reaffirmed.MRE
Q2 202523 Nov 2025 - Margins and adjusted EPS improved in Q3 2025 despite lower sales and free cash flow.MRE
Q3 202515 Nov 2025